自身免疫性疾病与1型糖尿病的治疗
utoimmune disease and type 1 diabetes treatment
自身免疫性疾病是危害人类健康的疾病之一,1型糖尿病是其中一种器官特异性疾病, 其发病是基因和环境因素综合作用的结果,主要与抗原特异性的自身反应性CD4+和CD8+ T细胞攻击胰岛β细胞有关,结果导致机体胰岛素的绝对缺乏。一些自身抗原如胰岛素、谷氨酸脱羧酶和酪氨酸磷酸酶等是触发该自身免疫反应的靶抗原,而免疫细胞、细胞因子、趋化因子及炎性介质等参与了该免疫过程。目前1型糖尿病在治疗上已有较大突破,粘膜免疫耐受抑制疾病的发生发展吸引了越来越多的目光,深入研究口服耐受的治疗机制将会为新的1型糖尿病的临床治疗提供坚实的基础。
utoimmune disease is a class of diseases endangering human health and one of them with organ specificity is type 1 diabetes(T1D). The T1D etiology is focusing on the combination functions of genetic and environmental factors and it was showed some self-reactive CD4 +and CD8+T cells were attacking the pancreatic β cells, resulting in the absolute lack of insulin. Identified self-antigens as insulin, glutamic acid decarboxylase (GAD65) triggered the reactions with the immune cells, cytokines, chemokines and inflammatory factors involved in the immune process. Nowadays, the T1D treatment already has some breakthroughs but oral tolerance curing autoimmune disease has attracted even more attentions .The study about the oral tolerance therapeutic mechanism will provide solid foundations for new clinical treatments of T1D.
孟巧红、金勇丰、张耀洲
基础医学内科学
自身免疫性疾病1型糖尿病口服耐受胰岛素
autoimmune diseasestype I diabetesoral toleranceinsulin
孟巧红,金勇丰,张耀洲.自身免疫性疾病与1型糖尿病的治疗[EB/OL].(2011-01-12)[2025-08-02].http://www.paper.edu.cn/releasepaper/content/201101-554.点此复制
评论